SCHEMBL25911896

SCHEMBL25911896

Cc1n(C)c2cnccc2[n+]1N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFATC1 O95644 1/20 0.37
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
ATM Q13315 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35
LCK P06239 1/20 0.33
RPS6KA5 O75582 1/20 0.33
MAPT P10636 7/20 0.32
TOP2A P11388 1/20 0.32
CYP19A1 P11511 1/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
CASP1 P29466 1/20 0.31
RAB9A P51151 1/20 0.31
CDC7 O00311 1/20 0.31
CDK2 P24941 1/20 0.31
HASPIN Q8TF76 1/20 0.31
POLB P06746 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25911898 0.86 ATM (0.38) NFATC1GSK3BDYRK1AATMADORA3
SCHEMBL25911924 0.76 RPS6KA5 (0.38) DYRK1AATMLCKRPS6KA5MEN1
SCHEMBL25911948 0.74 LCK (0.40) LCK
SCHEMBL25911892 0.73 GPR3 (0.38) LCKMAPTNPC1TP53RAB9A
SCHEMBL25911926 0.66 RPS6KA5 (0.40) ATMRPS6KA5CYP19A1SMN1; SMN2MEN1
SCHEMBL25911893 0.64 CYP1A2 (0.36) MAPTNPC1RAB9ACDC7CDK2
SCHEMBL25911899 0.64 ADORA3 (0.38) ADORA3ADORA2ARPS6KA5CYP19A1NPC1
SCHEMBL1609661 0.63 ADORA3 (0.54) NFATC1GSK3BDYRK1AATMADORA3
SCHEMBL25911853 0.62 TDO2 (0.35)
SCHEMBL12918543 0.60 DYRK1A (0.61) NFATC1GSK3BDYRK1AATMADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11716898-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11716898-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, JUND NFATC1 1675/4885GSK3B 3837/4885DYRK1A 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.